Atlas Trials

Cardiac Dysfunction

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Cardiac Dysfunction

RecordFirmDate
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). (NCT04433546)PhaseBio Pharmaceuticals Inc.2020-07-15
Football Players Health Study In Person Assessments Study (NCT03866564)Massachusetts General Hospital2019-04-22
Cardiac Dysfunction in Childhood Cancer Survivors (NCT03790943)University of Bern2018-02-13
Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient (NCT03085420)Shriners Hospitals for Children2017-05-03
Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO) (NCT02581280)Yonsei University2014-12-01
MicroRNA Diagnostics in Subarachnoid Hemorrhage 2 (NCT02320539)Rigshospitalet, Denmark2014-11-01
Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block (NCT02144766)Si-Qin Chen2014-04-01

Track Cardiac Dysfunction automatically

Every clearance here is in the API, with alerts when new ones post.